Adipose Stem Cell Banking
A quiet reserve — held for the decades to come.
Overview
Your own adipose-derived mesenchymal stem cells, harvested at their youngest available biological state and held in a private cryogenic reserve — a decision made once, benefiting decades of future medicine.
A minor, refined harvest of adipose tissue yields mesenchymal stem cells in their youngest available state. These are isolated, characterised, and cryopreserved under GMP-certified conditions with our Medeze partnership.
Held privately, they form a personal biological reserve — available for future regenerative protocols, cell-expansion therapies, and orthopaedic or aesthetic applications as science advances.
The Science
Why this works.
- 01
Adipose tissue contains one of the richest yields of mesenchymal stem cells (MSCs) in the human body — orders of magnitude greater than bone marrow, and accessible through a minor harvest.
- 02
The younger these cells are banked, the greater their proliferative capacity and epigenetic fidelity. Cells banked today outperform those isolated a decade from now.
- 03
Our Medeze partnership uses ISO-certified cleanroom processing and vapour-phase liquid nitrogen storage with dual-site redundancy, protecting viability for 20+ years.
The Process
A protocol conducted without theatre.
01
Consultation
A private session with the medical director to review candidacy, timing, and future-use scenarios.
02
Micro-harvest
A discreet lipoaspirate under local anaesthesia in the private procedure suite — approximately forty minutes.
03
Isolation & characterisation
Cells are isolated, viability-tested and phenotyped in a GMP-certified laboratory within hours of harvest.
04
Cryopreservation
Multiple aliquots are cryopreserved in vapour-phase liquid nitrogen with dual-site redundancy.
05
Custody & annual audit
You receive a private custody dossier; annual viability audits are provided in your member report.
Considered for
Members in their forties, fifties or sixties who wish to secure biological optionality before further ageing.
Those pursuing longevity as a multi-decade strategy rather than a single intervention.
Members with a family history of degenerative or orthopaedic conditions.
Outcomes
- →
A personal, indefinitely renewable source of autologous stem cells.
- →
Access to future regenerative, orthopaedic, cardiac and aesthetic applications as they receive clinical approval.
- →
No immunological rejection risk — the cells are your own.
All processing is conducted under Thai FDA oversight in partnership with Medeze, Southeast Asia's leading GMP-certified biobank.